Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-26

Clinical Trial Update: Analgesic Efficacy of Two Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating two doses of dexmedetomidine as adjuncts to lidocaine for intravenous regional anesthesia in limb deformity patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: Assiut University | Conditions: Limb Deformity | Phase 4 | Status: COMPLETED